November 6, 2017 Catalent Collaborates With Grid Therapeutics to Develop Novel Targeted Immuno-Oncology Therapy November 6, 2017 Catalent Pharma Solutions recently announced it has signed a multi-year agreement with Grid Therapeutics, LLC, for the development and manufacture...